New medical tools offer a potentially transformative approach to obesity treatment, marking a significant advancement in the field. However, questions are being raised regarding equitable access to these therapies. The article highlights a paradox: a groundbreaking medical progress may become available only to those who can afford it, creating a disparity in healthcare. This raises concerns about whether the benefits of this revolution will be widely available or limited to a privileged few. The piece suggests a lack of social progress accompanying the therapeutic advancement. Further discussion is needed to address the potential for this treatment to exacerbate existing health inequalities.